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ABSTRACT 
 
Chronic obstructive pulmonary disease (COPD) is a life-threatening inflammatory respiratory 
disorder, often induced by cigarette smoke (CS) exposure. The development of effective 
therapies is impaired by a lack of understanding of the underlining mechanisms. Tumor 
necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine with inflammatory 
and apoptotic properties. We interrogated a mouse model of CS-induced experimental COPD 
and human tissues to identify a novel role for TRAIL in COPD pathogenesis. CS exposure of 
wild-type mice increased TRAIL and its receptor messenger RNA (mRNA) expression and 
protein levels, as well as the number of TRAIL
+
CD11b
+
 monocytes in the lung. TRAIL and 
its receptor mRNA were also increased in human COPD. CS-exposed TRAIL-deficient mice 
had decreased pulmonary inflammation, pro-inflammatory mediators, emphysema-like 
alveolar enlargement, and improved lung function. TRAIL-deficient mice also developed 
spontaneous small airway changes with increased epithelial cell thickness and collagen 
deposition, independent of CS exposure. Importantly, therapeutic neutralization of TRAIL, 
after the establishment of early-stage experimental COPD, reduced pulmonary inflammation, 
emphysema-like alveolar enlargement, and small airway changes. These data provide further 
evidence for TRAIL being a pivotal inflammatory factor in respiratory diseases, and the first 
preclinical evidence to suggest that therapeutic agents that target TRAIL may be effective in 
COPD therapy. 
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